Eastman Chemical Company
Q2 2025 Earnings
Market Reaction
S&P 500 over the same 30 days: +3.54%.
Did EMN Beat Earnings? Q2 2025 Results
Eastman Chemical delivered a disappointing second quarter, missing on both the top and bottom lines as persistent macroeconomic headwinds continued to weigh on the specialty chemicals giant. Adjusted EPS came in at $1.60, falling short of the $1.75 consensus estimate by 8.71%, while revenue slipped 3.2% year-over-year to $2.29 billion, just below the $2.30 billion analysts had expected. The single most consequential drag beyond soft end-market demand was an unplanned outage in the Chemical Intermediates segment, which alone cost roughly $20 million in EBIT and helped swing that unit to a $30 million operating loss for the quarter. S&P Global Ratings responded by revising its outlook on the company to negative, citing tariff exposure and weakening product demand. Looking ahead, management guided Q3 adjusted EPS to approximately $1.25, flagging a planned inventory reduction of more than $200 million that will create a $75 to $100 million asset utilization headwind in the second half, though full-year operating cash flow is still expected to reach approximately $1 billion, offering some reassurance for investors focused on <a href="https://247wallst.com/investing/2025/07/30/5-regular-payout-high-yield-vig-dividends-to-outpace-the-fed/">consistent dividend income</a>.
- Additives & Functional Products driven by mix improvement and leverage to stable end markets including care chemicals and heat transfer fluid project fulfillments
- Advanced Materials impacted by weak primary demand in building & construction and automotive OEM production, partially offset by specialty plastics growth
- Chemical Intermediates impacted by approximately $20 million unplanned outage and unfavorable commodity market fundamentals
- Fibers revenue declined 17% due to acetate tow customer inventory destocking, industry capacity share adjustments, and lower textiles sales into China due to global trade dispute
- Commercial excellence keeping price-cost in specialties stable and defending market share
“The second quarter presented significant challenges, and I am proud of the way our team fought to deliver resilient earnings in our specialty businesses. As expected, the macroeconomic backdrop showed little signs of seasonal improvements across our end markets. In this context, we worked hard to mitigate tariff impacts on our global business through supply chain and commercial excellence. The second quarter also had an approximately $20 million impact in Chemical Intermediates due to an unplanned outage, compounding what continues to be tougher conditions for commodity markets. The Kingsport methanolysis facility continues to operate well, and we remain on track to produce greater than 2.5 times more recycled content than 2024. Moving forward, we will continue to focus on cash generation with a disciplined approach to managing our cost structure, reducing working capital, and allocating capital.”
Eastman Chemical CEO, on the earnings call
Forward Guidance & Outlook
For Q3 2025, Eastman projects adjusted EPS of approximately $1.25. The company expects a decline in volume due to trade dispute impacts and normal seasonality. Eastman is executing plans to reduce inventory by more than $200 million below current levels, which will result in a $75-$100 million asset utilization headwind to earnings in H2 2025, with approximately $50 million in Q3. Partially offsetting headwinds are expected improvements in Chemical Intermediates earnings (after Q2 unplanned outage), continued ramp-up of cost-reduction initiatives, and increased revenue from the Kingsport methanolysis facility. Full-year 2025 operating cash flow is expected to be approximately $1 billion, as declines in cash earnings will be partially offset by a release of working capital. The company is maintaining its approach of providing only quarterly (rather than full-year) adjusted EPS guidance due to the wide range of potential outcomes from increased tariff levels and related uncertainty.
EMN YoY Financials
EMN Revenue by Segment
EMN Revenue by Geography
Figures from SEC filings and company reports. Not investment advice.